Literature DB >> 1719234

Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.

L Dillner1, P Heino, J Moreno-Lopez, J Dillner.   

Abstract

All types of papillomaviruses (PV) share common, so-called group-specific epitopes. To identify the major group-specific epitopes, we immunized 26 guinea pigs or rabbits with purified bovine PV type 1 (BPV), canine PV, or avian PV from the common chaffinch. The resulting hyperimmune sera, as well as a commercially available rabbit antiserum to BPV and seven monoclonal antibodies to BPV, were tested in an enzyme-linked immunosorbent assay with a set of 66 overlapping 20-amino-acid peptides representing the complete sequence of the major capsid proteins (L1 and L2) of human PV type 16 (HPV 16). Sera from the same animals before immunization were used as controls. The minimal reactive epitopes within each peptide were further characterized by testing of truncated peptides. The cross-reactive epitopes were clustered in two regions of L1, an internal region (at positions 171 to 235), which contained three epitopes, and the more reactive region at the carboxy terminus (at positions 411 to 475), which contained six epitopes. The most reactive of the HPV 16 broadly cross-reactive epitopes was a carboxy-terminal epitope which had the sequence DTYRF and which reacted with nine of the antisera to BPV, canine PV, or avian PV, with the commercially available rabbit antiserum to BPV, and also with a mouse monoclonal antibody to BPV. Antipeptide antisera to all of the HPV 16 L1 peptides and to the most antigenically reactive of their truncated analogs were made in guinea pigs. Antipeptide antisera reactive with BPV were obtained for three of the cross-reactive epitopes, and one of these antisera allowed highly sensitive detection of group-specific PV antigen by immunoperoxidase staining.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719234      PMCID: PMC250784     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Nucleotide sequence of the HPV16 L1 open reading frame.

Authors:  A Parton
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

2.  Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.

Authors:  L Banks; G Matlashewski; D Pim; M Churcher; C Roberts; L Crawford
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

3.  The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn.

Authors:  H J Dyson; K J Cross; R A Houghten; I A Wilson; P E Wright; R A Lerner
Journal:  Nature       Date:  1985 Dec 5-11       Impact factor: 49.962

4.  Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera.

Authors:  C C Li; K V Shah; A Seth; R V Gilden
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Expression of human papillomavirus types 6b and 16 L1 open reading frames in Escherichia coli: detection of a 56,000-dalton polypeptide containing genus-specific (common) antigens.

Authors:  Y Tomita; H Shirasawa; B Simizu
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

6.  Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.

Authors:  E Norrby; G Biberfeld; F Chiodi; A von Gegerfeldt; A Nauclér; E Parks; R Lerner
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

7.  Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens.

Authors:  Y Nakai; W D Lancaster; L Y Lim; A B Jenson
Journal:  Intervirology       Date:  1986       Impact factor: 1.763

8.  Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.

Authors:  J Dillner
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

9.  Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.

Authors:  M Müller; H Gausepohl; G de Martynoff; R Frank; R Brasseur; L Gissmann
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

10.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

View more
  12 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Authors:  Daniel Oberg; Brian Collier; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  mRNA instability elements in the human papillomavirus type 16 L2 coding region.

Authors:  M Sokolowski; W Tan; M Jellne; S Schwartz
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.

Authors:  P Le Cann; A Touze; N Enogat; D Leboulleux; C Mougin; M C Legrand; C Calvet; J M Afoutou; P Coursaget
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Oral immunogenicity of human papillomavirus-like particles expressed in potato.

Authors:  Heribert Warzecha; Hugh S Mason; Christopher Lane; Anders Tryggvesson; Edward Rybicki; Anna-Lise Williamson; John D Clements; Robert C Rose
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.

Authors:  A Wikström; C Eklund; G Von Krogh; P Lidbrink; J Dillner
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33.

Authors:  C Volpers; M Sapp; C A Komly; P Richalet-Secordel; R E Streeck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.

Authors:  L Dillner; A Fredriksson; E Persson; O Forslund; B G Hansson; J Dillner
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA.

Authors:  G J Van Doornum; M Prins; L Pronk; R A Coutinho; J Dillner
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

10.  Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1.

Authors:  W Tan; B K Felber; A S Zolotukhin; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.